CDNA צמיחה צפויה ברווח נקי למניה השנה caredx.com
The annual earnings per share growth rate on the precise GURU.Markets chart is recorded at 207.40. CareDx, Inc (CDNA) is protected from economic crises due to the critical importance of transplant monitoring. CareDx, Inc (CDNA) leads in non-invasive diagnostics, offering an alternative to biopsies through AlloSure tests. The brand is currently successfully restoring the trust of the professional community, strengthening its market position.
פילוחי מדדים פיננסיים ומדדי שוק עבור caredx.com (CDNA)
CareDx, Inc (CDNA) revenues depend on insurance reimbursements for transplant rejection diagnostics, meaning the current YoY EPS growth reflects the actual monetization efficiency within this medical niche. This indicator measures the annual trend in earnings per share, enabling value investors to identify local price bottoms and generate alpha, provided there is strict control over the business's debt load.
